Recently, many new anticancer agents have become available for the treatment of prostate cancer—Zytiga, Xtandi, Xofigo, Provenge and Jevtana, but differing opinions about optimal combinations and sequencing will naturally arise. If we adopt the belief that treatment effectiveness is enhanced when used against earlier-stage cancer, thoughts are engendered about using two or three treatments simultaneously. READ THE FULL ARTICLE HERE > https://www.verywell.com/starting-treatment-early-for-metastatic-prostate-cancer-part-iv-3901453